18F-FDDNP

N/A

Report date: 2025/11/24 17:58:24
NME

Base Information

Drug Name18F-FDDNP
Drug Alias NameN/A
ClassificationSmall moleculesRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18F +[5] 
Mechanisms of ActionBeta amyloid A4 protein modulators
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsDiagnostic agentsAlzheimer DiseaseBrain Injuries, Traumatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSiemens Medical SolutionUniversity Of California At Los Angeles
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of California At Los AngelesSiemens Medical Solution
Active IndicationsN/A
Inactive IndicationsDiagnostic agentsAlzheimer DiseaseBrain Injuries, Traumatic

Other Information

ATC CodeN/A
Related LinksN/A